{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:58:47Z","timestamp":1772758727203,"version":"3.50.1"},"reference-count":19,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2000,3,1]],"date-time":"2000-03-01T00:00:00Z","timestamp":951868800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2000,3]]},"DOI":"10.1006\/gyno.1999.5713","type":"journal-article","created":{"date-parts":[[2002,10,6]],"date-time":"2002-10-06T21:31:24Z","timestamp":1033939884000},"page":"418-422","source":"Crossref","is-referenced-by-count":17,"title":["Xp22.2-3 Loss of Heterozygosity Is Associated with Germline BRCA1 Mutation in Ovarian Cancer"],"prefix":"10.1006","volume":"76","author":[{"given":"Thomas E.","family":"Buekers","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas A.","family":"Lallas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard E.","family":"Buller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1006\/gyno.1999.5713_RF1","first-page":"186","article-title":"The prognostic significance of X chromosome inactivation in ovarian cancer","volume":"4","author":"Buekers","year":"1999","journal-title":"CME J Gynecol Oncol"},{"key":"10.1006\/gyno.1999.5713_RF2","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1093\/jnci\/91.4.339","article-title":"Non-random X-chromosome inactivation in germline ovarian cancer DNA is associated with BRCA1 mutation","volume":"91","author":"Buller","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"10.1006\/gyno.1999.5713_RF3","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1006\/gyno.1995.1244","article-title":"Absence of significant germline p53 mutations in ovarian cancer patients","volume":"58","author":"Buller","year":"1995","journal-title":"Gynecol Oncol"},{"key":"10.1006\/gyno.1999.5713_RF4","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1006\/gyno.1996.0122","article-title":"p53 allelotypes and enhanced detection of allelic loss in ovarian cancer: Lack of correlation with familial and clinical factors","volume":"61","author":"Skilling","year":"1996","journal-title":"Gynecol Oncol"},{"key":"10.1006\/gyno.1999.5713_RF5","first-page":"308","article-title":"Report of the sixth international workshop on X chromosome mapping 1995","volume":"71","author":"Nelson","year":"1995","journal-title":"Cytogenet Cell Genet"},{"key":"10.1006\/gyno.1999.5713_RF6","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1101\/gr.7.3.210","article-title":"X chromosome map at 75-kb STS resolution, revealing extremes of recombination and GC content","volume":"7","author":"Nagaraja","year":"1997","journal-title":"Genome Res"},{"key":"10.1006\/gyno.1999.5713_RF7","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0140-6736(92)91334-5","article-title":"Detection of full fragile X mutation","volume":"339","author":"Pergolizzi","year":"1992","journal-title":"Lancet"},{"key":"10.1006\/gyno.1999.5713_RF8","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/(SICI)1098-2264(199702)18:2<75::AID-GCC1>3.0.CO;2-Y","article-title":"Analysis of loss of heterozygosity and Kras2 mutations in ovarian neoplasms: Clinicopathologic correlations","volume":"18","author":"Chevenix-Trench","year":"1997","journal-title":"Genes Chrom Cancer"},{"key":"10.1006\/gyno.1999.5713_RF9","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/sj.onc.1201479","article-title":"A one centiMorgan deletion unit on chromosome Xq12 is commonly lost in borderline and invasive ovarian tumors","volume":"16","author":"Edelson","year":"1998","journal-title":"Oncogene"},{"key":"10.1006\/gyno.1999.5713_RF10","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/ijc.2910520414","article-title":"Frequent loss of heterozygosity on chromosomes Xp and 13q in human ovarian cancer","volume":"52","author":"Yang-Feng","year":"1992","journal-title":"Int J Cancer"},{"key":"10.1006\/gyno.1999.5713_RF11","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/ijc.2910540405","article-title":"Allelic loss in ovarian cancer","volume":"54","author":"Yang-Feng","year":"1993","journal-title":"Int J Cancer"},{"key":"10.1006\/gyno.1999.5713_RF12","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1006\/mgme.1999.2871","article-title":"BRCA1 mutations in familial ovarian cancer","volume":"67","author":"Lallas","year":"1999","journal-title":"Mol Gen Metab"},{"key":"10.1006\/gyno.1999.5713_RF13","first-page":"273","article-title":"Localization of a gene that escapes inactivation to the X chromosome proximal short arm: Implications for X inactivation","volume":"46","author":"Brown","year":"1990","journal-title":"Am J Hum Genet"},{"key":"10.1006\/gyno.1999.5713_RF14","first-page":"2499","article-title":"Genomic instability in ovarian cancer: A reassessment using arbitrarily primed polymerase chain reaction","volume":"13","author":"Sood","year":"1996","journal-title":"Oncogene"},{"key":"10.1006\/gyno.1999.5713_RF15","unstructured":"Chen, J, J, Silver, D, Cantor, S, Livingston, D, M, Scully, R, BRCA1, BRCA2,, and Rad51 operate in a common DNA damage response pathway. Cancer Res 59:1752S\u2013 1756S"},{"key":"10.1006\/gyno.1999.5713_RF16","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/bjc.1994.79","article-title":"Polymerase chain reaction allelotyping of human ovarian cancer","volume":"69","author":"Osbourne","year":"1994","journal-title":"Br J Cancer"},{"key":"10.1006\/gyno.1999.5713_RF17","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/(SICI)1098-2264(199711)20:3<234::AID-GCC3>3.0.CO;2-3","article-title":"Loss of heterozygosity at chromosome segment Xq25-26.1 in advanced human ovarian carcinomas","volume":"20","author":"Choi","year":"1997","journal-title":"Genes Chrom Cancer"},{"key":"10.1006\/gyno.1999.5713_RF18","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0092-8674(00)80936-8","article-title":"BRCA1, BRCA2, and DNA damage response: Collision or collusion","volume":"92","author":"Zhang","year":"1998","journal-title":"Cell"},{"key":"10.1006\/gyno.1999.5713_RF19","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1038\/sj.onc.1201861","article-title":"BAP1: A novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression","volume":"16","author":"Jensen","year":"1998","journal-title":"Oncogene"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009082589995713X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009082589995713X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T02:21:12Z","timestamp":1557282072000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009082589995713X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,3]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2000,3]]}},"alternative-id":["S009082589995713X"],"URL":"https:\/\/doi.org\/10.1006\/gyno.1999.5713","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2000,3]]}}}